CN110105327A — 一种7,8-二氟-6,11-二氢-二苯并噻吩并-11-醇的制备方法
Assigned to Nanjing Huanran Biotechnology Co Ltd · Expires 2019-08-09 · 7y expired
What this patent protects
本发明涉及一种7,8‑二氟‑6,11‑二氢‑二苯并噻吩并‑11‑醇的制备方法,具体涉及以2,3‑二氟甲苯作为原料,经过溴化反应、氰基化反应、苄溴化反应、取代反应、水解反应、环合反应、还原反应高效合成7,8‑二氟‑6,11‑二氢‑二苯并噻吩并‑11‑醇。本发明提供的巴洛沙韦中间体7,8‑二氟‑6,11‑二氢‑二苯并[B,E]噻吩并‑11‑醇的制备方法是一种高收率、低成本、环保、易操作、适宜工业化的制备方法。
USPTO Abstract
本发明涉及一种7,8‑二氟‑6,11‑二氢‑二苯并噻吩并‑11‑醇的制备方法,具体涉及以2,3‑二氟甲苯作为原料,经过溴化反应、氰基化反应、苄溴化反应、取代反应、水解反应、环合反应、还原反应高效合成7,8‑二氟‑6,11‑二氢‑二苯并噻吩并‑11‑醇。本发明提供的巴洛沙韦中间体7,8‑二氟‑6,11‑二氢‑二苯并[B,E]噻吩并‑11‑醇的制备方法是一种高收率、低成本、环保、易操作、适宜工业化的制备方法。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.